Product image
InVivoMAb anti-mouse IL-6
BE0046
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse IL-6
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDMP5-20F3
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG1
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment. Benevides L et al., 2015 Sep 15, Cancer ResRead more
- Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication. Liang Y et al., 2015 May 20, Sci RepRead more
- IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age. Tsukamoto H et al., 2015 Apr 7, Nat CommunRead more
- Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-alpha levels. Jose S et al., 2014 Sep 3, J NeuroinflammationRead more
- Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Khmaladze Ia et al., 2014 Sep 2, Proc Natl Acad Sci U S ARead more
- Donor CD4 T cells trigger costimulation blockade-resistant donor bone marrow rejection through bystander activation requiring IL-6. Hock K et al., 2014 Sep, Am J TransplantRead more
- Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome. Barber DL et al., 2014 Jan 15, J ImmunolRead more
- CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection. Kugler DG et al., 2013 Sep 23, J Exp MedRead more
- SOCS3 transactivation by PPARgamma prevents IL-17-driven cancer growth. Berger H et al., 2013 Jun 15, Cancer ResRead more
- Th17 alloimmunity prevents neonatal establishment of lymphoid chimerism in IL-4-deprived mice. Debock I et al., 2012 Jan, Am J TransplantRead more